Page last updated: 2024-09-03

gefitinib and Spinal Neoplasms

gefitinib has been researched along with Spinal Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andratschke, N; Hildebrandt, G; Kuhnt, T; Lewitzki, V1
Ishikawa, H; Kikuchi, N; Ohara, G; Satoh, H; Sekizawa, K1
Chang, JW; Cheung, YC; Chou, WC; Hsieh, JJ; Huang, SF; Liu, MY; Wang, HM; Yeh, KY1
Debus, J; Hof, H; Welzel, T1

Other Studies

4 other study(ies) available for gefitinib and Spinal Neoplasms

ArticleYear
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib.
    Radiation oncology (London, England), 2015, Jan-29, Volume: 10

    Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Gefitinib; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Myelitis; Palliative Care; Quinazolines; Radiation Injuries; Spinal Neoplasms; Thoracic Vertebrae

2015
Prolonged response to gefitinib in bone metastasis.
    Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Back Pain; Carboplatin; Disease Progression; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Protein Kinase Inhibitors; Quinazolines; Spinal Neoplasms; Time Factors

2009
Different responses to gefitinib in lung adenocarcinoma coexpressing mutant- and wild-type epidermal growth factor receptor genes.
    Japanese journal of clinical oncology, 2006, Volume: 36, Issue:8

    Topics: Adenocarcinoma; Antineoplastic Agents; Drug Resistance, Neoplasm; Gefitinib; Genes, erbB-1; Humans; Laminectomy; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Predictive Value of Tests; Protein Kinase Inhibitors; Quinazolines; Spinal Neoplasms

2006
Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.
    Onkologie, 2006, Volume: 29, Issue:12

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chordoma; Gefitinib; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Quinazolines; Sacrum; Spinal Neoplasms; Treatment Outcome

2006